AVP Receptor V Antibodies

Santa Cruz Biotechnology features a diverse variety of AVP Receptor V monoclonal antibodies for investigating vasopressin receptors in various physiological processes. AVP Receptor V monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AVP Receptor V, also known as the vasopressin V2 receptor, plays a critical role in regulating water balance and blood pressure by mediating the effects of vasopressin on renal function. Dysregulation of AVP Receptor V is associated with conditions such as diabetes insipidus and certain cardiovascular diseases, making it a significant target for therapeutic intervention. Understanding the function of AVP Receptor V is essential for advancing research in renal physiology and related disorders. AVP Receptor V monoclonal antibodies enable precise detection and characterization of receptor expression patterns across different tissues and experimental conditions. Researchers can leverage AVP Receptor V monoclonal antibodies to uncover new insights into vasopressin signaling pathways and their roles in cellular processes. The exceptional specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support scientists in making meaningful contributions to vasopressin receptor research and therapeutic development.